Ginkgo Bioworks isn’t letting any grass grow under its feet. Just a week after inking a $2.5 billion pact to go public via the special purpose acquisition company Soaring Eagle Acquisition Corp. (SRNG, Financial), the Boston-based company is expanding overseas.